Research ArticleBRAIN
Enhancing Patterns in Multiple Sclerosis: Evolution and Persistence
Juan He, Robert I. Grossman, Yulin Ge and Lois J. Mannon
American Journal of Neuroradiology April 2001, 22 (4) 664-669;
Juan He
Robert I. Grossman
Yulin Ge
References
- ↵Grossman RI, McGowan JC. Perspectives on multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1251-1265
- Fazekas F, Barkhof F, Filippi M, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999;53:448-456
- Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24
- ↵Simon JH. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis. J Magn Reson Imaging 1997;7:29-37
- ↵Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16
- Barkhof F, Scheltens P, Frequin ST, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992;159:1041-1047
- Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62
- ↵Koudriavtseva T, Thompson AJ, Fiorelli M, et al. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:285-287
- Filippi M, Rocca MA, Horsfield MA, Comi G. A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads. J Neurol Sci 1998;158:203-208
- ↵Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
- ↵Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049
- ↵Simon JH. From enhancing lesions to brain atrophy in relapsing MS. J Neuroimmunol 1999;98:7-15
- ↵Kappos L, Moeri D, Radue WE, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Lancet 1999;353:964-969
- ↵Guttmann CRG, AHN SS, Hsu L, Kikinis R, Jolesz FA. The evolution of multiple sclerosis lesions on serial MR. AJNR Am J Neuroradiol 1995;16:1481-1491
- ↵Hickey WF. The pathology of multiple sclerosis: a historical perspective. J Neuroimmunol 1999;98:37-44
- Raine CS. Part two—neuropathology and etipathogenesis. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple Sclerosis: Clinical and Pathogenic Basis. London, New York: Chapman & Hall Medical 1997;159-170
- ↵Bastianello S, Pozzilli C, Bernardi S, et al. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990;40:591-595
- Filippi M, Rocca MA, Sormani MP, Pereira C, Comi G. Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging. Magn Reson Imaging 1999;17:979-984
- ↵Rovira A, Alonso J, Cucurella G, et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol 1999;20:1939-1945
- Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491
- Hiehle JF, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison of gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77
- ↵Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-555
- ↵Kwon EE, Prineas JW. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:625-636
- ↵Claudio L, Raine CS, Brosnan CF. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 1995;90:228-238
- ↵Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium enhanced magnetic resonance imaging. Ann Neurol 1987;21:300-306
- Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280
- Filippi M, Rossi P, Campi A, Colombo B, Pereira C, Comi G. Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. AJNR Am J Neuroradiol 1997;18:1549-1556
- ↵Rosenblum D, Saffir M. The natural history of multiple sclerosis and its diagnosis. Phys Rehabil Clin N Am 1998;9:537-549
- ↵Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-474
- ↵Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996;46:379-384
- ↵Rovaris M, Mastronardo G, Prandini F, Bastianello S, Comi G, Filippi M. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans. J Neurol Sci 1999;164:148-152
- ↵Rovaris M, Rodegher M, Comi G. Filippi M. Correlation between MRI and short-term clinical activity in multiple sclerosis: comparison between standard- and triple-dose Gd-enhanced MRI. Eur Neurol 1999;41:123-127
In this issue
Advertisement
Enhancing Patterns in Multiple Sclerosis: Evolution and Persistence
Juan He, Robert I. Grossman, Yulin Ge, Lois J. Mannon
American Journal of Neuroradiology Apr 2001, 22 (4) 664-669;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Cerebral enhancement in MOG antibody-associated disease
- Cerebral enhancement in MOG antibody-associated disease
- Growth differentiation factor 15 is increased in stable MS
- Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences
- MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis
- Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation
- Tumefactive demyelination: an approach to diagnosis and management
- A weak leg
- Tumefactive demyelination-to cracks the nut without cracking the pot
- Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients
- MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement